CARDINAL HEALTH INC
S-4/A, 1998-12-14
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: CARDINAL HEALTH INC, S-4, 1998-12-14
Next: MNI GROUP INC, NT 10-Q, 1998-12-14



<PAGE>   1
 
   AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON DECEMBER 14, 1998
 
                                                 REGISTRATION NO. 333-
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
 
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                            ------------------------
   
                               Amendment No. 1
                                       to
    
                                    FORM S-4
                             REGISTRATION STATEMENT
                                     UNDER
                           THE SECURITIES ACT OF 1933
                            ------------------------
 
                             CARDINAL HEALTH, INC.
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
 
<TABLE>
<S>                                  <C>                                  <C>
                OHIO                                 5122                              31-0958666
  (STATE OR OTHER JURISDICTION OF        (PRIMARY STANDARD INDUSTRIAL               (I.R.S. EMPLOYER
   INCORPORATION OR ORGANIZATION)        CLASSIFICATION CODE NUMBER)              IDENTIFICATION NO.)
</TABLE>
 
                               5555 GLENDON COURT
                               DUBLIN, OHIO 43016
                                 (614) 717-5000
         (ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING
            AREA CODE, OF REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES)
                            ------------------------
 
                          GEORGE H. BENNETT, JR., ESQ.
            EXECUTIVE VICE PRESIDENT, GENERAL COUNSEL AND SECRETARY
                             CARDINAL HEALTH, INC.
                               5555 GLENDON COURT
                               DUBLIN, OHIO 43016
                                 (614) 717-5000
           (NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER,
                   INCLUDING AREA CODE, OF AGENT FOR SERVICE)
 
                                 WITH COPIES TO
 
<TABLE>
<S>                                                    <C>
                DAVID A. KATZ, ESQ.                                    JOHN A. BICK, ESQ.
          WACHTELL, LIPTON, ROSEN & KATZ                              DAVIS POLK & WARDWELL
                51 WEST 52ND STREET                                   450 LEXINGTON AVENUE
              NEW YORK, NY 10019-6150                                  NEW YORK, NY 10017
                  (212) 403-1000                                         (212) 450-4000
</TABLE>
 
                            ------------------------
 
    APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:  As soon as
practicable after the effective date of the Registration Statement.
 
    If the securities being registered on this form are being offered in
connection with the formation of a holding company and there is compliance with
General Instruction G, check the following box. [ ]
 
    If this form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective
registration statement for the same offering. [ ]
 
    If this form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
                            ------------------------
 
                        CALCULATION OF REGISTRATION FEE
 
<TABLE>
<CAPTION>
- ---------------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------------
          TITLE OF EACH                                       PROPOSED MAXIMUM        PROPOSED MAXIMUM           AMOUNT OF
       CLASS OF SECURITIES              AMOUNT TO BE           OFFERING PRICE            AGGREGATE              REGISTRATION
        TO BE REGISTERED                 REGISTERED             PER SHARE(1)         OFFERING PRICE(1)             FEE(2)
- ---------------------------------------------------------------------------------------------------------------------------------
<S>                                <C>                     <C>                     <C>                     <C>
Common Shares, without par value    81,547,500 shares       $68.67                  $5,600,250,000          $1,556,870
- ---------------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------------
</TABLE>
 
(1) Pursuant to Rule 457(f)(1) and 457(c) promulgated under the Securities Act
    of 1933, as amended, and estimated solely for purposes of calculating the
    registration fee, the proposed maximum aggregate offering price is
    $5,600,250,000, which equals the average of the high and low prices of the
    common stock, par value $1.00 per share ("Allegiance Common Stock"), of
    Allegiance Corporation ("Allegiance"), of $42.75, as reported on the New
    York Stock Exchange on December 8, 1998, multiplied by the total number of
    shares of Allegiance Common Stock (including shares issuable pursuant to the
    exercise of outstanding options to purchase Allegiance Common Stock or
    otherwise in connection with the Merger) to be canceled in the merger (the
    "Merger") of a subsidiary of Cardinal Health, Inc. ("Cardinal") with and
    into Allegiance. The proposed maximum offering price per share is equal to
    the proposed maximum aggregate offering price determined in the manner
    described in the preceding sentence divided by the maximum number of
    Cardinal common shares, without par value, that could be issued in the
    Merger based on an exchange ratio of 0.6225.
 
   
(2) Of this amount, $917,585.46 was paid in connection with the filing by
    Cardinal Health, Inc. on December 2, 1998 of preliminary proxy materials on
    Schedule 14A in connection with the Merger, and the balance was paid upon
    the filing of the Registration Statement on December 14, 1998.
    

                            ------------------------
    THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF
THE SECURITIES ACT OF 1933, AS AMENDED, OR UNTIL THIS REGISTRATION STATEMENT
SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID
SECTION 8(a), MAY DETERMINE.
 
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>   2
 
ITEM 21. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
 
(a) EXHIBITS.
   
<TABLE>
<CAPTION>
<S>    <C>
2.01   Agreement and Plan of Merger, dated as of October 8, 1998,
       by and among the Registrant, Boxes Merger Corp., and
       Allegiance Corporation.(1)
2.02   Stock Option Agreement, dated as of October 8, 1998, by and
       between the Registrant and Allegiance Corporation.(2)
2.03   Voting/Support Agreement, dated as of October 8, 1998, by
       and between the Registrant and Lester B. Knight.(2)
2.04   Voting/Support Agreement, dated as of October 8, 1998, by
       and between the Registrant and Joseph F. Damico.(2)
2.05   Amendment to Rights Agreement, dated as of October 8, 1998,
       by and between Allegiance Corporation and First Chicago
       Trust Company of New York.(3)
2.06   Amendment to Change in Control Agreement, dated as of
       October 8, 1998, by and among the Registrant, Allegiance
       Corporation and Lester B. Knight.(1)
2.07   Amendment to Change in Control Agreement, dated as of
       October 8, 1998, by and among the Registrant, Allegiance
       Corporation and Joseph F. Damico.(1)
3.01   Amended and Restated Articles of Incorporation of the
       Registrant, as amended.(4)
3.02   Restated Code of Regulations of the Registrant, as
       amended.(4)
4.01   Specimen Certificate for the Registrant's Class A Common
       Shares.(5)
5      Opinion of Wachtell, Lipton, Rosen & Katz as to the legality
       of the shares being issued.(1)
8      Opinion of Davis Polk & Wardwell as to certain tax matters.
23.01  Consent of Deloitte & Touche LLP (Cardinal).(1)
23.02  Consent of PricewaterhouseCoopers LLP (Allegiance).(1)
23.03  Consent of Ernst & Young LLP (Cardinal).(1)
23.04  Consent of PricewaterhouseCoopers LLP (Cardinal).(1)
23.05  Consent of Arthur Andersen LLP (Cardinal).(1)
23.06  Consent of Wachtell, Lipton, Rosen & Katz (included in
       Exhibit 5).
23.07  Consent of Davis Polk & Wardwell (included in Exhibit 8).
23.08  Consent of Credit Suisse First Boston Corporation.(1)
23.09  Consent of Morgan Stanley & Co. Incorporated.(1)
24     Power of Attorney.
99.01  Form of Proxy Card of the Registrant.(1)
99.02  Form of Proxy Card of Allegiance Corporation.(1)
</TABLE>
    
 
- ---------------
   
(1) Previously filed.
    
 
(2) Included as an exhibit to the Registrant's Schedule 13D (Commission File No.
    5-48909).
 
(3) Included as an exhibit to Amendment No. 1 to the Registration Statement on
    Form 8-A/A filed October 9, 1998 of Allegiance Corporation.
 
(4) Included as an exhibit to the Registrant's 8-K filed November 24, 1998
    (Commission File No. 0-12591).
 
(5) Included as an exhibit to the Registrant's Annual Report on Form 10-K for
    the fiscal year ended June 30, 1997 and incorporated herein by reference.
 
(b) FINANCIAL STATEMENT SCHEDULES.
 
    Schedule II -- Valuation and Qualifying Accounts (incorporated by reference
    from the Registrant's Current Report on Form 8-K/A filed September 28,
    1998).
 
<PAGE>   3
 
                                   SIGNATURES
 
   
     Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing this Amendment No. 1 to the Registration Statement on
Form S-4 and has duly caused this Amendment No. 1 to the Registration Statement
to be signed on its behalf by the undersigned, thereunto duly authorized, in the
City of Dublin, State of Ohio, on the 14th day of December, 1998.
 
                                         CARDINAL HEALTH, INC.
 

                                         By:                 *
                                            -----------------------------------
                                            Robert D. Walter
                                            Chairman and Chief Executive Officer
    
 
   
     Pursuant to the requirements of the Securities Act of 1933, this Amendment 
No. 1 to the Registration Statement on Form S-4 has been signed by the following
persons in the capacities indicated on the 14th day of December, 1998.
    
 
   
<TABLE>
<CAPTION>
SIGNATURE                                           TITLE
- ---------                                           -----
<S>                                                 <C>

 
                       *                            Chairman and Chief Executive Officer (principal
- ------------------------------------------------    executive officer) and Director
Robert D. Walter
 
                       *                            Vice President, Acting Chief Financial Officer,
- ------------------------------------------------    Controller and Principal Accounting Officer
Richard J. Miller
 
                       *                            Director
- ------------------------------------------------
Aleksander Erdeljan
 
                       *                            Director
- ------------------------------------------------
John F. Finn
 
                       *                            Director
- ------------------------------------------------
Robert L. Gerbig
 
                       *                            Director
- ------------------------------------------------
John F. Havens
 
                       *                            Director
- ------------------------------------------------
Regina E. Herzlinger
 
                       *                            Director
- ------------------------------------------------
John C. Kane
 
                       *                            Director
- ------------------------------------------------
J. Michael Losh
 
                       *                            Director
- ------------------------------------------------
George R. Manser
</TABLE>
    

           
<PAGE>   4
   
 
<TABLE>
<CAPTION>
SIGNATURE                                           TITLE
- ---------                                           -----
<S>                                                 <C>
                        *                           Director
- ------------------------------------------------
John B. McCoy
 
                        *                           Director
- ------------------------------------------------
Jerry E. Robertson
 
                        *                           Director
- ------------------------------------------------
L. Jack Van Fossen
 
                        *                           Director
- ------------------------------------------------
Melburn G. Whitmire

*By: /s/ George H. Bennett, Jr.
     -------------------------------------------
     George H. Bennett, Jr.
     Attorney-in-Fact
</TABLE>
    
 
<PAGE>   5
  
                                 EXHIBIT INDEX
   
<TABLE>
<CAPTION>
EXHIBIT
NUMBER   EXHIBIT DESCRIPTION
- -------  -------------------
<S>      <C>
2.01     Agreement and Plan of Merger, dated as of October 8, 1998,
         by and among the Registrant, Boxes Merger Corp., and
         Allegiance Corporation.(1)
2.02     Stock Option Agreement, dated as of October 8, 1998, by and
         between the Registrant and Allegiance Corporation.(2)
2.03     Voting/Support Agreement, dated as of October 8, 1998, by
         and between the Registrant and Lester B. Knight.(2)
2.04     Voting/Support Agreement, dated as of October 8, 1998, by
         and between the Registrant and Joseph F. Damico.(2)
2.05     Amendment to Rights Agreement, dated as of October 8, 1998,
         by and between Allegiance Corporation and First Chicago
         Trust Company of New York.(3)
2.06     Amendment to Change in Control Agreement, dated as of
         October 8, 1998, by and among the Registrant, Allegiance
         Corporation and Lester B. Knight.(1)
2.07     Amendment to Change in Control Agreement, dated as of
         October 8, 1998, by and among the Registrant, Allegiance
         Corporation and Joseph F. Damico.(1)
3.01     Amended and Restated Articles of Incorporation of the
         Registrant, as amended.(4)
3.02     Restated Code of Regulations of the Registrant, as
         amended.(4)
4.01     Specimen Certificate for the Registrant's Class A Common
         Shares.(5)
5        Opinion of Wachtell, Lipton, Rosen & Katz as to the legality
         of the shares being issued.(1)
8        Opinion of Davis Polk & Wardwell as to certain tax matters.
23.01    Consent of Deloitte & Touche LLP (Cardinal).(1)
23.02    Consent of PricewaterhouseCoopers LLP (Allegiance).(1)
23.03    Consent of Ernst & Young LLP (Cardinal).(1)
23.04    Consent of PricewaterhouseCoopers LLP (Cardinal).(1)
23.05    Consent of Arthur Andersen LLP (Cardinal).(1)
23.06    Consent of Wachtell, Lipton, Rosen & Katz (included in
         Exhibit 5).
23.07    Consent of Davis Polk & Wardwell (included in Exhibit 8).
23.08    Consent of Credit Suisse First Boston Corporation.(1)
23.09    Consent of Morgan Stanley & Co. Incorporated.(1)
24       Power of Attorney.
99.01    Form of Proxy Card of the Registrant.(1)
99.02    Form of Proxy Card of Allegiance Corporation.(1)
</TABLE>
    
 
   
- ---------------
(1) Previously filed.
    
 
(2) Included as an exhibit to the Registrant's Schedule 13D (Commission File No.
    5-48909).
 
(3) Included as an exhibit to Amendment No. 1 to the Registration Statement on
    Form 8-A/A filed October 9, 1998 of Allegiance Corporation.
 
(4) Included as an exhibit to the Registrant's 8-K filed November 24, 1998
    (Commission File No. 0-12591).
 
(5) Included as an exhibit to the Registrant's Annual Report on Form 10-K for
    the fiscal year ended June 30, 1997 and incorporated herein by reference.
 

<PAGE>   1
                                                                       Exhibit 8

                            [DAVIS POLK & WARDWELL]
   
    

                                  212-450-4000


   
                                                  December 14, 1998
    



Allegiance Corporation
1430 Waukegan Road
McGaw Park, Illinois 60005


Ladies and Gentlemen:

     We have acted as counsel for Allegiance Corporation, a Delaware corporation
("ALLEGIANCE"), in connection with the merger (the "MERGER") of Boxers Merger
Corp., a Delaware corporation and a wholly-owned subsidiary of Cardinal Health,
Inc., an Ohio corporation ("CARDINAL"), with and into Allegiance pursuant to an
Agreement and Plan of Merger dated as of October 8, 1998 (the "AGREEMENT")(1),
among Allegiance, Cardinal and Boxes Merger Corp. Under the Agreement each
issued and outstanding share of Allegiance Common Stock(2) will be converted
into the right to receive 0.6225 of a Cardinal Common Share.

   
     In that connection, you have requested, pursuant to Section 6.2(d) of the 
Agreement, our opinion regarding certain federal income tax consequences of the 
Merger. In providing our opinion, we have examined and relied upon the 
Agreement, the Joint Proxy Statement/Prospectus dated December 14, 1998 (the 
"Joint Proxy Statement/Prospectus"), and such other documents and corporate 
records as we have deemed necessary or appropriate for purposes of our opinion. 
In addition, we have (i) assumed that the Merger will be consummated in 
accordance with the provisions of the
    

- ----------------------

     (1)References contained in this opinion to the Agreement include each 
document attached as an exhibit or annex.

     (2)Capitalized terms used herein and not otherwise defined have the 
meanings set forth in the Agreement.
<PAGE>   2
   
  Allegiance Corporation                2                   December 14, 1998
    


   
Agreement and (ii) relied on the representations made to us by Cardinal and 
Allegiance in their respective letters to us dated December 14, 1998, which 
were delivered to us for purposes of this opinion, and which are represented to 
be true, correct and complete.
    

     Based upon and subject to the foregoing, in our opinion the Merger will be 
treated for federal income tax purposes as a reorganization within the meaning 
of Section 368(a) of the Internal Revenue Code of 1986, as amended (the 
"Code"), Allegiance, Cardinal and Boxes Merger Corp. will each be a party to 
that reorganization and, pursuant to Section 354 of the Code, no gain or loss 
will be recognized by the stockholders of Allegiance upon their receipt of 
Cardinal Common Shares in exchange for Allegiance Common Stock (except to the 
extent that a stockholder receives cash in respect of fractional shares).

     We are members of the Bar of the State of New York. The opinions expressed 
herein are based upon existing statutory, regulatory and judicial authority, 
any of which may be changed at any time with retroactive effect. In addition, 
our opinions are based solely on the documents that we have examined, and the 
statements contained in the letters from Cardinal and Allegiance referred to 
above, which have been represented to be true, correct and complete as of the 
dates thereof. Our opinions cannot be relied upon if any of the facts pertinent 
to the federal income tax treatment of the Merger stated in such documents is, 
or later becomes, inaccurate, or if any of the statements contained in the 
letters from Cardinal or Allegiance referred to above are, or later become, 
inaccurate or incomplete. Finally, our opinions are limited to the tax matters 
specifically covered hereby, and we have not been asked to address, nor have we 
addressed any other tax consequences of the Merger or any other transactions.

     We are furnishing this opinion solely to you in connection with the 
transactions contemplated by the Agreements, and it is not to be relied upon, 
used, circulated, quoted, or otherwise referred to for any other purpose or by 
any other party without our prior written consent.

     We hereby consent to the filing of this opinion as an exhibit to the 
Registration Statement and to the use of our name under the captions "Certain 
United States Federal Income Tax Consequences" and "Legal Matters" in the Joint 
Proxy Statement/Prospectus. The issuance of such consent does not concede that 
we are an "expert" for the purposes of the Securities Act of 1933.

                                             Very truly yours,

   
                                             /s/ Davis Polk & Wardwell
    



                                       2


<PAGE>   1
                                                                      EXHIBIT 24

                       REGISTRATION STATEMENT ON FORM S-4
                                POWER OF ATTORNEY



   
                  Each of the undersigned officers and Directors of Cardinal
Health, Inc., an Ohio corporation (the "Company"), which proposes to file with
the Securities and Exchange Commission a Registration Statement on Form S-4 or
other appropriate form under the Securities Act of 1933, as amended, with
respect to the merger of Boxes Merger Corp. with and into Allegiance
Corporation, and the Common Shares of the Company issuable in connection
therewith, hereby constitutes and appoints Robert D. Walter, George H. Bennett,
Jr., and Brendan A. Ford and each of them, severally, as his/her
attorney-in-fact and agent, with full power of substitution and resubstitution,
in his/her name and on his/her behalf, to sign in any and all capacities such
Registration Statement and any and all amendments (including post-effective
amendments on Form S-4, Form S-8 or otherwise) and exhibits thereto, and any and
all applications and other documents relating thereto, with full power and
authority to perform and do any and all acts and things whatsoever which any
such attorney or substitute may deem necessary or advisable to be performed or
done in connection with any or all of the above-described matters, as fully as
each of the undersigned could do if personally present and acting, hereby
ratifying and approving all acts of any such attorney or substitute.
    

                  This Power of Attorney has been signed in the respective
capacities and on the respective dates indicated below.
   

<TABLE>
<CAPTION>
<S>                                              <C>
 /s/ Robert D. Walter                               /s/  John C. Kane
- --------------------------------------            --------------------------------------
Robert D. Walter                                  John C. Kane
Chairman, Chief Executive Officer and             Director,    December 11, 1998
Director,               December 11, 1998         
                                                  
  /s/ Richard J. Miller                             /s/  J. Michael Losh
- --------------------------------------            --------------------------------------
Richard J. Miller                                 J. Michael Losh
Vice President, Acting Chief Financial Officer,   Director,    December 11, 1998
Controller and Principal Accounting Officer,       
                         December 11, 1998         
                                                  
  /s/  Aleksander Erdeljan                          /s/  George R. Manser
- --------------------------------------            --------------------------------------
Aleksander Erdeljan                               George R. Manser
Director,                December 11, 1998         Director,   December 11, 1998
                                                  
                                                  
  /s/  John F. Finn                                 /s/  John B. McCoy
- --------------------------------------            --------------------------------------
John F. Finn                                      John B. McCoy
Director,                December 11, 1998         Director,   December 11, 1998
                                                  
                                                  
  /s/  Robert L. Gerbig                             /s/  Jerry E. Robertson
- --------------------------------------            --------------------------------------
Robert L. Gerbig                                  Jerry E. Robertson
Director,                December 11, 1998         Director,   December 11, 1998
                                                  
                                                  
  /s/  John F. Havens                               /s/  L. Jack Van Fossen
- --------------------------------------            --------------------------------------
John F. Havens                                    L. Jack Van Fossen
Director,                December 11, 1998         Director,     December 11, 1998
                                                  
                                                  
  /s/  Regina E. Herzlinger                         /s/  Melburn G. Whitmire
- --------------------------------------            --------------------------------------
Regina E. Herzlinger                              Melburn G. Whitmire
Director,                December 11, 1998         Director,    December 11, 1998
</TABLE>
    


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission